Paxlovid Tied to Benefits in High-Risk Patients With COVID Paxlovid Tied to Benefits in High-Risk Patients With COVID

The use of nirmatrelvir –ritonavir (Paxlovid) is associated with a lower risk for death or hospitalization in extremely vulnerable patients with COVID-19. Low-risk patients do not appear to benefit.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news